Lili Kong

Lili Kong

Auto-generated profile, based on publicly available information

Lili Kong

College of Chemistry & Pharmacy, Northwest A&F University, Yangling, Shaanxi 712100, China

Research Focus & Metrics

Academic Career Length

18Years (2009-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2013 in Journal of Diabetes Research
Verified
Journal Article
Open access
PDF file
LKLi-Li Kong
Li-Li Kong
HWHao Wu
Hao Wu
WCWen-Peng Cui
Wen-Peng Cui
WZWen-Hua Zhou
Wen-Hua Zhou
PLPing Luo
Ping Luo
LMLi-Ning Miao
Li-Ning Miao
Diabetic nephropathy (DN) is one of the microvascular complications of both type 1 and type 2 diabetes, which is also associated with a poor life expectancy of diabetic patients. However, the pathogenesis of DN is still unclear. Thus, it is of great use to establish appropriate animal models of DN for doing research on pathogenesis and developing novel therapeutic strategies. Although a large number of murine models of DN including artificially induced, spontaneous, and genetically engineered (knockout and transgenic) animal models have been developed, none of them develops renal changes sufficiently reflecting those seen in humans. Here we review the identified murine models of DN from the aspects of genetic background, type of diabetes, method of induction, gene deficiency, animal age and gender, kidney histopathology, and phenotypic alterations in the hope of enhancing our comprehension of genetic susceptibility and molecular mechanisms responsible for this disease and providing new clues as to how to choose appropriate animal models of DN.

30 November 2021 in Diabetes & Metabolism Journal
Verified
Journal Article
Open access
PDF file
LKLili Kong
Lili Kong
HWHongyue Wang
Hongyue Wang
CLChenhao Li
Chenhao Li
HCHuiyan Cheng
Huiyan Cheng
YCYan Cui
Yan Cui
YZYing Zhao
Ying Zhao
Background: The dietary agent sulforaphane (SFN) has been reported to reduce diabetes-induced renal fibrosis, as well as inhibit histone deacetylase (HDAC) activity. Bone morphologic protein 7 (BMP-7) has been shown to reduce renal fibrosis induced by transforming growth factor-beta1. The aim of this study was to investigate the epigenetic effect of SFN on BMP-7 expression in diabetes-induced renal fibrosis.Methods: Streptozotocin (STZ)-induced diabetic mice and age-matched controls were subcutaneously injected with SFN or vehicle for 4 months to measure the in vivo effects of SFN on the kidneys. The human renal proximal tubular (HK11) cell line was used to mimic diabetic conditions in vitro. HK11 cells were transfected to over-express HDAC2 and treated with high glucose/palmitate (HG/Pal) to explore the epigenetic modulation of BMP-7 in SFN-mediated protection against HG/Pal-induced renal fibrosis.Results: SFN significantly attenuated diabetes-induced renal fibrosis in vivo. Among all of the HDACs we detected, HDAC2 activity was markedly elevated in the STZ-induced diabetic kidneys and HG/Pal-treated HK11 cells. SFN inhibited the diabetes-induced increase in HDAC2 activity which was associated with histone acetylation and transcriptional activation of the BMP-7 promoter. HDAC2 over-expression reduced BMP-7 expression and abolished the SFN-mediated protection against HG/Pal-induced fibrosis in vitro.Conclusion: Our study demonstrates that the HDAC inhibitor SFN protects against diabetes-induced renal fibrosis through epigenetic up-regulation of BMP-7.

1 January 2017 in Oxidative Medicine and Cellular Longevity
Verified
Journal Article
Open access
PDF file
LKLili Kong
Lili Kong
YWYangwei Wang
Yangwei Wang
MLManyu Luo
Manyu Luo
YTYi Tan
Yi Tan
WCWenpeng Cui
Wenpeng Cui
LMLining Miao
Lining Miao
Our previous study showed that proteasomal inhibitor MG132 can prevent diabetic nephropathy (DN) along with upregulation of nuclear factor (erythroid‐derived 2)‐like 2 (Nrf2). The present study was to investigate whether MG132 can prevent DN in wild‐type and Nrf2‐KO mice. Type 1 diabetes was induced in wild‐type and Nrf2‐KO mice by multiple low doses of streptozotocin. Two weeks after streptozotocin injection, both wild‐type and Nrf2‐KO mice were randomly divided into four groups: control, MG132, DM, and DM/MG132. MG132 (10 μg/kg/day) or vehicle was administered intraperitoneally for 4 months. Renal function, morphology, and biochemical changes were measured after 4‐month treatment with MG132. MG132 treatment suppressed proteasomal activity in the two genotypes. In wild‐type mice, MG132 attenuated diabetes‐induced renal dysfunction, fibrosis, inflammation, and oxidative damage along with increased Nrf2 and IκB expression. Deletion of Nrf2 gene resulted in a partial, but significant attenuation of MG132 renal protection in Nrf2‐KO mice compared with wild‐type mice. MG132‐increased IκB expression was not different between wild‐type and Nrf2‐KO mice. This work indicates that MG132 inhibits diabetes‐increased proteasomal activity, resulting in Nrf2 and IκB upregulation and renal protection, which could be used as a strategy to prevent diabetic nephropathy.

16 January 2017 in Oxidative Medicine and Cellular Longevity
Verified
Journal Article
Open access
PDF file
YWYonggang Wang
Yonggang Wang
HWHao Wu
Hao Wu
YXYing Xin
Ying Xin
YBYang Bai
Yang Bai
LKLili Kong
Lili Kong
Lu CaiLu Cai
Lu Cai
Although angiotensin II (Ang II) was reported to facilitate sperm motility and intratesticular sperm transport, recent findings shed light on the efficacy of Ang II in stimulating inflammatory events in testicular peritubular cells, effect of which may play a role in male infertility. It is still unknown whether Ang II can induce testicular apoptotic cell death, which may be a more direct action of Ang II in male infertility. Therefore, the present study aims to determine whether Ang II can induce testicular apoptotic cell death and whether this action can be prevented by sulforaphane (SFN) via activating nuclear factor (erythroid‐derived 2)‐like 2 (NRF2), the governor of antioxidant‐redox signalling. Eight‐week‐old male C57BL/6J wild type (WT) and Nrf2 gene knockout mice were treated with Ang II, in the presence or absence of SFN. In WT mice, SFN activated testicular NRF2 expression and function, along with a marked attenuation in Ang II‐induced testicular oxidative stress, inflammation, endoplasmic reticulum stress, and apoptotic cell death. Deletion of the Nrf2 gene led to a complete abolishment of these efficacies of SFN. The present study indicated that Ang II may result in testicular apoptotic cell death, which can be prevented by SFN via the activation of NRF2.

1 March 2022 in Journal of Colloid and Interface Science
Verified
Journal Article
Closed access
ZLZehao Li
Zehao Li
HBHu Bai
Hu Bai
JWJielu Wei
Jielu Wei
JWJunjie Wang
Junjie Wang
LKLili Kong
Lili Kong
JDJinyou Duan
Jinyou Duan